Home › Funds › SECTORAL ASSET MANAGEMENT INC › AVTX
SECTORAL ASSET MANAGEMENT INC position in AVTX
AVALO THERAPEUTICS INC · Health Care
SECTORAL ASSET MANAGEMENT INC reported holding 177,294 shares of AVTX (AVALO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.7M, representing 2.02% of its reported portfolio and ranking #15 among its reported holdings. SECTORAL ASSET MANAGEMENT INC has disclosed AVTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SECTORAL ASSET MANAGEMENT INC's AVTX position evolved
SECTORAL ASSET MANAGEMENT INC first disclosed a stake in AVTX in Q2 2026 at 119,923 shares (US$2.2M). The position peaked in Q3 2026 at 177,294 shares, worth US$2.7M. Across 2 filings, SECTORAL ASSET MANAGEMENT INC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 177,294 shares valued at US$2.7M — an increase of 57,371 shares quarter over quarter.. Notable position changes include a 48% increase in Q3 2026 (shares fell 49% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 119.92K | $2.22M | New |
| Q3 2026 | 177.29K | $2.72M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AVTX and 13F data
AVTX (AVALO THERAPEUTICS INC) is a Health Care company. 80 other funds we track also report a position in AVTX — the largest reported positions include Deep Track Capital, LP (US$66.7M), Caligan Partners LP (US$58.5M), TCG Crossover Management, LLC (US$55.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AVTX
- Deep Track Capital, LP 3.61M sh · $66.71M · Q2 2026
- Caligan Partners LP 3.16M sh · $58.47M · Q2 2026
- TCG Crossover Management, LLC 3.02M sh · $55.76M · Q2 2026
- Affinity Asset Advisors, LLC 2.90M sh · $53.59M · Q2 2026
- Farallon Capital Management 2.50M sh · $46.16M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.50M sh · $46.16M · Q2 2026
- Avoro Capital Advisors LLC 2.33M sh · $43.12M · Q2 2026
- BVF INC/IL 2.08M sh · $38.36M · Q2 2026
- Nantahala Capital Management, LLC 1.86M sh · $34.41M · Q2 2026
- Soleus Capital Management, L.P. 1.65M sh · $30.58M · Q2 2026
- BRAIDWELL LP 1.63M sh · $30.11M · Q2 2026
- Logos Global Management LP 1.15M sh · $21.25M · Q2 2026
More on SECTORAL ASSET MANAGEMENT INC
FAQ
How long has SECTORAL ASSET MANAGEMENT INC held AVTX?
SECTORAL ASSET MANAGEMENT INC has disclosed AVTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is SECTORAL ASSET MANAGEMENT INC's current position in AVTX?
As of Q3 2026, SECTORAL ASSET MANAGEMENT INC holds 177.29K shares of AVTX (AVALO THERAPEUTICS INC), valued at $2.72M, representing 2.02% of its reported portfolio and ranking #15.
Has SECTORAL ASSET MANAGEMENT INC been buying or selling AVTX?
In the latest 13F filing (Q3 2026), SECTORAL ASSET MANAGEMENT INC increased its position in AVTX. The position peaked in Q3 2026 at 177.29K shares.
Which other funds hold AVTX?
Other major institutional holders of AVTX include Deep Track Capital, LP, Caligan Partners LP, TCG Crossover Management, LLC, among 80 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.